Cover Kidney News
Volume/Issue:
Volume 14: Issue 12
Page:
10
Publication Date:
01 Dec 2022
Online Publication Date:
06 Dec 2022
  • 1.

    Schlaich MP, et al. Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): A multicentre, blinded, randomised, parallel-group, phase 3 trial. Lancet, published online ahead of print November 4, 2022. doi: 10.1016/S0140-6736(22)02034-7; https://doi.org/10.1016/S0140-6736(22)02034-7

    • PubMed
    • Search Google Scholar
    • Export Citation
Editorial Type:
Feature

Endothelin Antagonist Improves Control of Resistant Hypertension

Volume/Issue:
Volume 14: Issue 12
Publication Date:
01 Dec 2022
Page:
10
Restricted access
Save